Skip to main content
Erschienen in: Rheumatology International 7/2013

01.07.2013 | Original Article

The association of TNFRSF1A gene and MEFV gene mutations with adult onset Still’s disease

verfasst von: Fulya Cosan, Zeliha Emrence, Gokhan Erbag, Hulya Azakli, Baris Yilmazer, Ayten Yazici, Sema Sirma Ekmekci, Neslihan Abaci, Duran Ustek, Ayse Cefle

Erschienen in: Rheumatology International | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Adult onset Still’s disease (ASD) is a systemic inflammatory disorder of unknown etiology. ASD is characterized by fever with unknown etiology, rash, arthritis, and involvement of several organ systems. FMF and TRAPS are two important autoinflammatory diseases which characterized with recurrent inflammatory attacks. We aimed in this study to investigate the MEFV gene and TNFRSF1A gene variations in ASD. Twenty consecutive Turkish ASD patients (14 female and 6 male; mean age 38.45 ± 14; mean disease duration 3.3 ± 2.3; mean age of the disease onset 35.1 ± 14.4) and 103 healthy controls of Turkish origin were analyzed. All ASD patients were genotyped for the 4 MEFV mutations (M694V, E148Q, V726A, M680I) and TNFRSF1A gene exon 2–3 and exon 4–5 by using sequence analysis. The healthy controls are genotyped using PCR–RFLP method for intron 4 variation. The results of MEFV gene mutations screening show an increase in the MEFV mutation rate in ASD group, but it was not significantly different (p = 0.442, OR 1.64, 95 % CI 0.409–6.589). T–C polymorphism (rs1800692) was the only variation in the intron 4 of TNFRSF1A gene that we observed at the ASD patients. The frequency of TT genotype was 15 %, TC: 45 %, and CC: 40 % in ASD patients and the frequencies were 22, 41, and 37 % in healthy controls, respectively. When we analyzed the allele difference between both groups, there was no difference (p = 0.54, OR 1.24, 0.619–2.496–2.654). The variations in MEFV may have role in ASD pathogenesis. Our findings suggest that there is no significant association between ASD and TNFRSF1A variations.
Literatur
1.
Zurück zum Zitat Henderson C, Goldbach-Mansky R (2010) Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis. Curr Opin Rheumatol 22:567–578PubMed Henderson C, Goldbach-Mansky R (2010) Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis. Curr Opin Rheumatol 22:567–578PubMed
2.
Zurück zum Zitat Grateau G, Duruöz MT (2010) Autoinflammatory conditions: when to suspect? How to treat? Best Pract Res Clin Rheumatol 24:401–411PubMedCrossRef Grateau G, Duruöz MT (2010) Autoinflammatory conditions: when to suspect? How to treat? Best Pract Res Clin Rheumatol 24:401–411PubMedCrossRef
3.
Zurück zum Zitat French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31CrossRef French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31CrossRef
4.
Zurück zum Zitat Cosan F, Ustek D, Oku B, Duymaz-Tozkir J, Cakiris A, Abaci N, Ocal L, Aral O, Gül A (2010) Association of familial Mediterranean fever-related MEFV variations with ankylosing spondylitis. Arthritis Rheum 62:3232–3236PubMedCrossRef Cosan F, Ustek D, Oku B, Duymaz-Tozkir J, Cakiris A, Abaci N, Ocal L, Aral O, Gül A (2010) Association of familial Mediterranean fever-related MEFV variations with ankylosing spondylitis. Arthritis Rheum 62:3232–3236PubMedCrossRef
5.
Zurück zum Zitat Akkoc N, Sari I, Akar S, Binicier O, Thomas MG, Weale ME, Birlik M, Savran Y, Onen F, Bradman N, Plaster CA (2010) Increased prevalence of M694V in patients with ankylosing spondylitis: additional evidence for a link with familial Mediterranean fever. Arthritis Rheum 62:3059–3063PubMedCrossRef Akkoc N, Sari I, Akar S, Binicier O, Thomas MG, Weale ME, Birlik M, Savran Y, Onen F, Bradman N, Plaster CA (2010) Increased prevalence of M694V in patients with ankylosing spondylitis: additional evidence for a link with familial Mediterranean fever. Arthritis Rheum 62:3059–3063PubMedCrossRef
6.
Zurück zum Zitat Koca SS, Etem EO, Isik B, Yuce H, Ozgen M, Dag MS, Isik A (2010) Prevalence and significance of MEFV gene mutations in a cohort of patients with rheumatoid arthritis. Joint Bone Spine 77:32–35PubMedCrossRef Koca SS, Etem EO, Isik B, Yuce H, Ozgen M, Dag MS, Isik A (2010) Prevalence and significance of MEFV gene mutations in a cohort of patients with rheumatoid arthritis. Joint Bone Spine 77:32–35PubMedCrossRef
7.
Zurück zum Zitat Rabinovich E, Livneh A, Langevitz P, Brezniak N, Shinar E, Pras M, Shinar Y (2005) Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis 64:1009–1014PubMedCrossRef Rabinovich E, Livneh A, Langevitz P, Brezniak N, Shinar E, Pras M, Shinar Y (2005) Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis 64:1009–1014PubMedCrossRef
8.
Zurück zum Zitat Yıldırım B, Tuncer C, Kan D, Tunc B, Demirag MD, Ferda Percın E, Haznedaroglu S, Alagozlu H (2011) MEFV gene mutations and its impact on the clinical course in ulcerative colitis patients. Rheumatol Int 31:859–864PubMedCrossRef Yıldırım B, Tuncer C, Kan D, Tunc B, Demirag MD, Ferda Percın E, Haznedaroglu S, Alagozlu H (2011) MEFV gene mutations and its impact on the clinical course in ulcerative colitis patients. Rheumatol Int 31:859–864PubMedCrossRef
9.
Zurück zum Zitat Giaglis S, Mimidis K, Papadopoulos V, Thomopoulos K, Sidiropoulos P, Rafail S, Nikolopoulou V, Fragouli E, Kartalis G, Tzioufas A, Boumpas D, Ritis K (2006) Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect? Dig Dis Sci 51:687–692PubMedCrossRef Giaglis S, Mimidis K, Papadopoulos V, Thomopoulos K, Sidiropoulos P, Rafail S, Nikolopoulou V, Fragouli E, Kartalis G, Tzioufas A, Boumpas D, Ritis K (2006) Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect? Dig Dis Sci 51:687–692PubMedCrossRef
10.
Zurück zum Zitat Ayaz NA, Ozen S, Bilginer Y, Ergüven M, Taşkiran E, Yilmaz E, Beşbaş N, Topaloğlu R, Bakkaloğlu A (2009) MEFV mutations in systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford) 48:23–25CrossRef Ayaz NA, Ozen S, Bilginer Y, Ergüven M, Taşkiran E, Yilmaz E, Beşbaş N, Topaloğlu R, Bakkaloğlu A (2009) MEFV mutations in systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford) 48:23–25CrossRef
11.
Zurück zum Zitat Rozenbaum M, Rosner I (2004) Severe outcome of juvenile idiopathic arthritis (JIA) associated with familial Mediterranean fever (FMF). Clin Exp Rheumatol 22:75–78 Rozenbaum M, Rosner I (2004) Severe outcome of juvenile idiopathic arthritis (JIA) associated with familial Mediterranean fever (FMF). Clin Exp Rheumatol 22:75–78
12.
Zurück zum Zitat Villani AC, Lemire M, Louis E, Silverberg MS, Collette C, Fortin G, Nimmo ER, Renaud Y, Brunet S, Libioulle C, Belaiche J, Bitton A, Gaudet D, Cohen A, Langelier D, Rioux JD, Arnott ID, Wild GE, Rutgeerts P, Satsangi J, Vermeire S, Hudson TJ, Franchimont D (2009) Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn’s disease and ulcerative colitis. PLoS ONE 4:e7154PubMedCrossRef Villani AC, Lemire M, Louis E, Silverberg MS, Collette C, Fortin G, Nimmo ER, Renaud Y, Brunet S, Libioulle C, Belaiche J, Bitton A, Gaudet D, Cohen A, Langelier D, Rioux JD, Arnott ID, Wild GE, Rutgeerts P, Satsangi J, Vermeire S, Hudson TJ, Franchimont D (2009) Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn’s disease and ulcerative colitis. PLoS ONE 4:e7154PubMedCrossRef
13.
Zurück zum Zitat Ozçakar ZB, Yalçinkaya F, Cakar N, Acar B, Kasapçopur O, Ugüten D, Soy D, Kara N, Uncu N, Arisoy N, Ekim M (2008) MEFV mutations modify the clinical presentation of Henoch-Schönlein purpura. J Rheumatol 35:2427–2429PubMedCrossRef Ozçakar ZB, Yalçinkaya F, Cakar N, Acar B, Kasapçopur O, Ugüten D, Soy D, Kara N, Uncu N, Arisoy N, Ekim M (2008) MEFV mutations modify the clinical presentation of Henoch-Schönlein purpura. J Rheumatol 35:2427–2429PubMedCrossRef
14.
Zurück zum Zitat Bayram C, Demircin G, Erdoğan O, Bülbül M, Caltik A, Akyüz SG (2011) Prevalence of MEFV gene mutations and their clinical correlations in Turkish children with Henoch-Schönlein purpura. Acta Paediatr 100:745–749PubMedCrossRef Bayram C, Demircin G, Erdoğan O, Bülbül M, Caltik A, Akyüz SG (2011) Prevalence of MEFV gene mutations and their clinical correlations in Turkish children with Henoch-Schönlein purpura. Acta Paediatr 100:745–749PubMedCrossRef
15.
Zurück zum Zitat Yalçinkaya F, Ozçakar ZB, Kasapçopur O, Oztürk A, Akar N, Bakkaloğlu A, Arisoy N, Ekim M, Ozen S (2007) Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. J Pediatr 151:675–678PubMedCrossRef Yalçinkaya F, Ozçakar ZB, Kasapçopur O, Oztürk A, Akar N, Bakkaloğlu A, Arisoy N, Ekim M, Ozen S (2007) Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. J Pediatr 151:675–678PubMedCrossRef
16.
Zurück zum Zitat Derré J, Kemper O, Cherif D, Nophar Y, Berger R, Wallach D (1991) The gene for the type 1 tumor necrosis factor receptor (TNF-R1) is localized on band 12p13. Hum Genet 87:231–233PubMedCrossRef Derré J, Kemper O, Cherif D, Nophar Y, Berger R, Wallach D (1991) The gene for the type 1 tumor necrosis factor receptor (TNF-R1) is localized on band 12p13. Hum Genet 87:231–233PubMedCrossRef
17.
Zurück zum Zitat McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, Mansfield E, Gadina M, Karenko L, Pettersson T, McCarthy J, Frucht DM, Aringer M, Torosyan Y, Teppo AM, Wilson M, Karaarslan HM, Wan Y, Todd I, Wood G, Schlimgen R, Kumarajeewa TR, Cooper SM, Vella JP, Amos CI, Mulley J, Quane KA, Molloy MG, Ranki A, Powell RJ, Hitman GA, O’Shea JJ, Kastner DL (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor (TNFR1) define a family of dominantly inherited auto-inflammatory syndromes. Cell 97:133–144PubMedCrossRef McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, Mansfield E, Gadina M, Karenko L, Pettersson T, McCarthy J, Frucht DM, Aringer M, Torosyan Y, Teppo AM, Wilson M, Karaarslan HM, Wan Y, Todd I, Wood G, Schlimgen R, Kumarajeewa TR, Cooper SM, Vella JP, Amos CI, Mulley J, Quane KA, Molloy MG, Ranki A, Powell RJ, Hitman GA, O’Shea JJ, Kastner DL (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor (TNFR1) define a family of dominantly inherited auto-inflammatory syndromes. Cell 97:133–144PubMedCrossRef
18.
Zurück zum Zitat Lachmann HJ, Hawkins PN (2009) Developments in the scientific and clinical understanding of autoinflammatory disorders. Arthritis Res Therapy 11:212CrossRef Lachmann HJ, Hawkins PN (2009) Developments in the scientific and clinical understanding of autoinflammatory disorders. Arthritis Res Therapy 11:212CrossRef
19.
Zurück zum Zitat Padeh S, Berkun Y (2007) Auto-inflammatory fever syndromes. Rheum Dis Clin North Am 33:585–623PubMedCrossRef Padeh S, Berkun Y (2007) Auto-inflammatory fever syndromes. Rheum Dis Clin North Am 33:585–623PubMedCrossRef
20.
Zurück zum Zitat Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, Dean J, Powell RJ, Kastner DL (2002) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 81:349–368CrossRef Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, Dean J, Powell RJ, Kastner DL (2002) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 81:349–368CrossRef
21.
Zurück zum Zitat Nowlan ML, Drewe E, Bulsara H, Esposito N, Robins RA, Tighe PJ, Powell RJ, Todd I (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430 Nowlan ML, Drewe E, Bulsara H, Esposito N, Robins RA, Tighe PJ, Powell RJ, Todd I (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430
22.
Zurück zum Zitat Ustek D, Ekmekci CG, Selçukbiricik F, Cakiris A, Oku B, Vural B, Yanar H, Taviloglu K, Ozbek U, Gül A (2007) Association between reduced levels of MEFV messenger RNA in peripheral blood leukocytes and acute inflammation. Arthritis Rheum 56:345–350PubMedCrossRef Ustek D, Ekmekci CG, Selçukbiricik F, Cakiris A, Oku B, Vural B, Yanar H, Taviloglu K, Ozbek U, Gül A (2007) Association between reduced levels of MEFV messenger RNA in peripheral blood leukocytes and acute inflammation. Arthritis Rheum 56:345–350PubMedCrossRef
23.
Zurück zum Zitat Bagnari V, Colina M, Ciancio G, Govoni M, Trotta F (2010) Adult-onset Still’s disease. Rheumatol Int 30:855–862PubMedCrossRef Bagnari V, Colina M, Ciancio G, Govoni M, Trotta F (2010) Adult-onset Still’s disease. Rheumatol Int 30:855–862PubMedCrossRef
24.
Zurück zum Zitat Riera E, Olivé A, Narváez J, Holgado S, Santo P, Mateo L, Bianchi MM, Nolla JM (2011) Adult onset Still’s disease: review of 41 cases. Clin Exp Rheumatol 29:331–336PubMed Riera E, Olivé A, Narváez J, Holgado S, Santo P, Mateo L, Bianchi MM, Nolla JM (2011) Adult onset Still’s disease: review of 41 cases. Clin Exp Rheumatol 29:331–336PubMed
25.
Zurück zum Zitat Efthimiou P, Georgy S (2006) Pathogenesis and management of adult-onset Still’s disease. Semin Arthritis Rheum 36:144–152PubMedCrossRef Efthimiou P, Georgy S (2006) Pathogenesis and management of adult-onset Still’s disease. Semin Arthritis Rheum 36:144–152PubMedCrossRef
26.
Zurück zum Zitat Dinarello CA (2011) A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur J Immunol 41:1203–1217PubMedCrossRef Dinarello CA (2011) A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur J Immunol 41:1203–1217PubMedCrossRef
27.
Zurück zum Zitat Masters SL, Lobito AA, Chae J, Kastner DL (2006) Recent advances in the molecular pathogenesis of hereditary recurrent fevers. Curr Opin Allergy Clin Immunol 6:428–433PubMedCrossRef Masters SL, Lobito AA, Chae J, Kastner DL (2006) Recent advances in the molecular pathogenesis of hereditary recurrent fevers. Curr Opin Allergy Clin Immunol 6:428–433PubMedCrossRef
28.
Zurück zum Zitat Rebelo SL, Amel-Kashipaz MR, Radford PM, Bainbridge SE, Fiets R, Fang J, McDermott EM, Powell RJ, Todd I, Tighe PJ (2009) Novel markers of inflammation identified in tumor necrosis factor receptor–associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line. Arthritis Rheumatism 60:269–280PubMedCrossRef Rebelo SL, Amel-Kashipaz MR, Radford PM, Bainbridge SE, Fiets R, Fang J, McDermott EM, Powell RJ, Todd I, Tighe PJ (2009) Novel markers of inflammation identified in tumor necrosis factor receptor–associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line. Arthritis Rheumatism 60:269–280PubMedCrossRef
29.
Zurück zum Zitat Aganna E, Hammond L, Hawkins PN, Aldea A, McKee SA, van Amstel HK, Mischung C, Kusuhara K, Saulsbury FT, Lachmann HJ, Bybee A, McDermott EM, La Regina M, Arostegui JI, Campistol JM, Worthington S, High KP, Molloy MG, Baker N, Bidwell JL, Castañer JL, Whiteford ML, Janssens-Korpola PL, Manna R, Powell RJ, Woo P, Solis P, Minden K, Frenkel J, Yagüe J, Mirakian RM, Hitman GA, McDermott MF (2003) Heterogeneity among patients with tumor necrosis factor receptor–associated periodic syndrome phenotypes. Arthritis Rheum 48:2632–2644PubMedCrossRef Aganna E, Hammond L, Hawkins PN, Aldea A, McKee SA, van Amstel HK, Mischung C, Kusuhara K, Saulsbury FT, Lachmann HJ, Bybee A, McDermott EM, La Regina M, Arostegui JI, Campistol JM, Worthington S, High KP, Molloy MG, Baker N, Bidwell JL, Castañer JL, Whiteford ML, Janssens-Korpola PL, Manna R, Powell RJ, Woo P, Solis P, Minden K, Frenkel J, Yagüe J, Mirakian RM, Hitman GA, McDermott MF (2003) Heterogeneity among patients with tumor necrosis factor receptor–associated periodic syndrome phenotypes. Arthritis Rheum 48:2632–2644PubMedCrossRef
30.
Zurück zum Zitat Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH, Goldbach-Mansky R, Dean J, Athreya B, Reginato AJ, Henrickson M, Pons-Estel B, O’Shea JJ, Kastner DL (2001) The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 69:301–314PubMedCrossRef Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH, Goldbach-Mansky R, Dean J, Athreya B, Reginato AJ, Henrickson M, Pons-Estel B, O’Shea JJ, Kastner DL (2001) The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 69:301–314PubMedCrossRef
31.
Zurück zum Zitat Seldin MF, Amos CI, Chen WV, Shigeta R, Monteiro J, Kern M, Criswell LA, Albani S, Nelson JL, Clegg DO, Pope R, Schroeder HW Jr, Bridges SL Jr, Pisetsky DS, Ward R, Kastner DL, Wilder RL, Pincus T, Callahan LF, Flemming D, Wener MH, Gregersen PK (2001) A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet 68:927–936PubMedCrossRef Seldin MF, Amos CI, Chen WV, Shigeta R, Monteiro J, Kern M, Criswell LA, Albani S, Nelson JL, Clegg DO, Pope R, Schroeder HW Jr, Bridges SL Jr, Pisetsky DS, Ward R, Kastner DL, Wilder RL, Pincus T, Callahan LF, Flemming D, Wener MH, Gregersen PK (2001) A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet 68:927–936PubMedCrossRef
32.
Zurück zum Zitat Nakamura M, Kobayashi M, Tokura Y (2009) A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) manifesting adult-onset Still disease-like skin eruptions: report of a case and review of the Japanese patients. Br J Dermatol 161:968–970PubMedCrossRef Nakamura M, Kobayashi M, Tokura Y (2009) A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) manifesting adult-onset Still disease-like skin eruptions: report of a case and review of the Japanese patients. Br J Dermatol 161:968–970PubMedCrossRef
34.
Zurück zum Zitat Jesus AA, Oliveira JB, Aksentijevich I, Fujihira E, Carneiro-Sampaio MM, Duarte AJ, Silva CA (2008) TNF receptor-associated periodic syndrome (TRAPS): description of a novel TNFRSF1A mutation and response to etanercept. Eur J Pediatr 167:1421–1425PubMedCrossRef Jesus AA, Oliveira JB, Aksentijevich I, Fujihira E, Carneiro-Sampaio MM, Duarte AJ, Silva CA (2008) TNF receptor-associated periodic syndrome (TRAPS): description of a novel TNFRSF1A mutation and response to etanercept. Eur J Pediatr 167:1421–1425PubMedCrossRef
35.
Zurück zum Zitat Huggins ML, Radford PM, McIntosh RS, Bainbridge SE, Dickinson P, Draper-Morgan KA, Tighe PJ, Powell RJ, Todd I (2004) Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor–associated periodic syndrome: differences between cell types. Arthritis Rheum 50:2651–2659PubMedCrossRef Huggins ML, Radford PM, McIntosh RS, Bainbridge SE, Dickinson P, Draper-Morgan KA, Tighe PJ, Powell RJ, Todd I (2004) Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor–associated periodic syndrome: differences between cell types. Arthritis Rheum 50:2651–2659PubMedCrossRef
36.
Zurück zum Zitat Todd I, Radford PM, Draper-Morgan KA, McIntosh R, Bainbridge S, Dickinson P, Jamhawi L, Sansaridis M, Huggins ML, Tighe PJ, Powell RJ (2004) Mutant forms of tumour necrosis factor receptorI that occur in TNF-receptor-associated periodic syndrome retain signaling functions but show abnormal behaviour. Immunology 113:65–79PubMedCrossRef Todd I, Radford PM, Draper-Morgan KA, McIntosh R, Bainbridge S, Dickinson P, Jamhawi L, Sansaridis M, Huggins ML, Tighe PJ, Powell RJ (2004) Mutant forms of tumour necrosis factor receptorI that occur in TNF-receptor-associated periodic syndrome retain signaling functions but show abnormal behaviour. Immunology 113:65–79PubMedCrossRef
37.
Zurück zum Zitat Siebert S, Amos N, Fielding CA, Wang EC, Aksentijevich I, Williams BD, Brennan P (2005) Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant. Arthritis Rheum 52:1287–1292PubMedCrossRef Siebert S, Amos N, Fielding CA, Wang EC, Aksentijevich I, Williams BD, Brennan P (2005) Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant. Arthritis Rheum 52:1287–1292PubMedCrossRef
38.
Zurück zum Zitat Lobito AA, Kimberley FC, Muppidi JR, Komarow H, Jackson AJ, Hull KM, Kastner DL, Screaton GR, Siegel RM (2006) Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood 108:1320–1327PubMedCrossRef Lobito AA, Kimberley FC, Muppidi JR, Komarow H, Jackson AJ, Hull KM, Kastner DL, Screaton GR, Siegel RM (2006) Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood 108:1320–1327PubMedCrossRef
Metadaten
Titel
The association of TNFRSF1A gene and MEFV gene mutations with adult onset Still’s disease
verfasst von
Fulya Cosan
Zeliha Emrence
Gokhan Erbag
Hulya Azakli
Baris Yilmazer
Ayten Yazici
Sema Sirma Ekmekci
Neslihan Abaci
Duran Ustek
Ayse Cefle
Publikationsdatum
01.07.2013
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 7/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2609-8

Weitere Artikel der Ausgabe 7/2013

Rheumatology International 7/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.